baber/WOPTO huggingface dataset:
Patent BR-PI0721176-B1 (BR)
Title: métodos e aparelhos para operar um turbo codificador
Inventor: AJIT NIMBALKER
IPC: H03M13/27
Filed: 2007-11-12
Abstract: métodos e aparelhos para operar um turbo codificador um método e aparelho para selecionar tamanhos de intercalador para turbo códigos é aqui provido. durante a operação o bloco de informação de tamanho k é recebido. um tamanho de intercalador k é determinado o qual é relacionado a k, onde k a partir de um conjunto de tamanhos; em que o conjunto de tamanhos compreende k''= a p x f , pmin menor igual a p menor igual a pmax ; fmin menor igual a f menor igual a fmax , em que a é um número inteiro e f é um número contínuo entre fmin e fmax, p pega os valores de números inteiros entre pmin e pmax, a>1, pmax> pmin, pmin>1. o bloco de informação de tamanho k é preenchido em um bloco de entrada de tamanho k utilizando bits de enchimento, se necessário. a codificação é realizada utilizando o bloco de entrada original e o bloco de entrada intercalado para obter um bloco de palavra-código utilizando um turbo codificador. o bloco de palavra-código é transmitido através do canal.
Patent BR-PI0812304-B1 (BR)
Title: Processo para a produção de p4o6
Inventor: WILLEM J SCHIPPER
IPC: C01B25/12
Filed: 2008-11-28
Abstract: PROCESSO PARA A PRODUÇÃO DE P4O6. A presente invenção refere-se a um processo para a produção de p4o6 de alta pureza, por reação de oxigênio, ou de uma mistura de oxigênio e um gás inerte, com fósforo líquido ou gasoso, para gerar o dito produto de reação em uma unidade de reação. O produto de reação é mantido na unidade de reação a uma temperatura média na faixa de 1.600 a 2.000 k, por remoção do calor criado pela reação exotérmica do fósforo e oxigênio. Um tempo de residência de pelo menos 1 segundo de reação passando pela unidade de reação é mantido. O produto de reação é então resfriado convencionalmente em uma unidade de têmpera, ligada à unidade de reação. O produto de reação final contém P4O6 com um teor muito baixo de fósforo elementar.
Patent BR-PI0813876-B1 (BR)
Inventor: TOSHIAKI MIYAUCHI
IPC: C08L61/06
Filed: 2008-01-29
Abstract: To provide an acrylic rubber composition and its vulcanized product, having excellent workability and an excellent balance of the vulcanization properties, the reduction of scorching, the rubber mechanical properties, the compression set and the heat resistance.  An acrylic rubber composition comprising a carboxy group-containing acrylic rubber, a novolac phenol resin salt of a diazabicycloalkene compound and a polyamine compound. Particularly, the diazabicycloalkene compound is preferably 2,3,4,6,7,8,9,10-octahydropyrimido(1,2-a)azepine or 2,3,4,6,7,8-hexahydropyrrolo(1,2-a)pyrimidine, and the polyamine compound is preferably an aromatic polyamine or an aliphatic polyamine.
Patent BR-PI0821510-B1 (BR)
Title: sistema de elevador com pelo menos uma cabine de elevador e processo para a operação de um sistema de elevador
Inventor: STEFFEN GRUNDMANN
IPC: B66B9/00
Filed: 2008-12-11
Abstract: sistema de elevador com pelo menos uma cabine de elevador e processo para a operação de um sistema de elevador a presente invenção refere-se a um sistema de elevador, com uma cabine de elevador (4), que pode executar viagens verticais e horizontais, sendo que, viagens verticais ocorrem ao longo de uma pista vertical (3) abrangendo um trilho de guia vertical (5), e viagens horizontais são executadas com auxílio de um dispositivo de transferência de cabine (13). o dispositivo de transferência de cabine (13) compreende uma unidade de deslocamento horizontal (16), na qual está integrada uma peça do trilho de guia (18), que leva a cabine de elevador (4) na unidade de deslocamento horizontal (16), sendo que, a unidade de deslocamento horizontal pode ser posicionada de tal modo que, a peça do trilho de guia (18) forma uma seção do trilho de guia vertical (5), e sendo que, durante o deslocamento horizontal, a cabine de elevador (4) pode ser fixada na peça do trilho de guia (18) por meio de um dispositivo de frenagem (20).
Patent BR-PI0905970-B1 (BR)
Title: Produção de hidrogênio para células a combustível de baixa temperatura a partir da reforma a vapor e da reforma oxidativa de álcoois, usando catalisadores a base de óxidos mistos com estrutura de perovskitas
Inventor: ADRIANA MARIA DA SILVA
IPC: C01B3/16
Filed: 2009-10-14
Abstract: produção de hidrogênio para células a combustível de baixa temperatura a partir da reforma a vapor e da reforma oxidativa de álcoois, usando catalisadores a base de óxidos mistos com estrutura de perovskitas. a presente invenção compreende a utilização de catalisadores a base de óxidos mistos contendo, pelo menos, lantânio, níquel e oxigênio nas reações de reforma a vapor e reforma oxidativa a baixa temperatura de álcoois ou de uma mistura destes álcoois, como por exemplo, bio-etanol. os catalisadores apresentam uma estrutura de perovskita representada por lai~ 1-x~m~ x~nio~ 3~ onde x 0,0 a 1,0 e m = elementos do grupo dos metais alcalinos terrosos ou dos lantanídeos. o hidrogênio gerado no método da invenção pode ser utilizado, dentre outras aplicações, em uma célula a combustível de baixa temperatura como as do tipo pem.
Patent BR-PI0907844-B1 (BR)
Title: compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos
Inventor: CHRIS P MILLER
IPC: C07D263/32
Filed: 2009-02-19
Abstract: MODULADORES SELETIVOS DO RECEPTOR DE ANDRÓGENO. A presente invenção refere-se a compostos de formulas (I), la, lb, Ic, Id, le e ou seus sais, composições farmacêuticas que compreendem um composto de fórmulas I, la, lb, lc, Id, le e um excipiente farmaceuticamente aceitável,métodos para modular o receptor de andrógeno, métodos para tratar doenças beneficamente tratadas por um modulador de andrógeno (por exemplo, sarcopenia, câncer da próstata, anticoncepção, distúrbios ou doenças relacionadas com a diabetes tipo 2, anemia, depressão e doença renal) e processos para preparar os compostos de fórmulas (I), la, lb, lc, ld,le e intermediários úteis na preparação dos mesmos.
Patent BR-PI1104127-B1 (BR)
Title: conexão submarina
Inventor: ARUMUGAM MAHENDRAN
IPC: H02G1/10
Filed: 2011-08-10
Abstract: CONEXÃO SUBMARINA A presente invenção está correlacionada a uma conexão ou interface submarina para uma estrutura recuperável, compreendendo um poste guia (8) e um receptáculo (3) para receber o poste guia. A conexão é adaptada para estabelecer, automaticamente, conexão elétrica entre o poste guia e o receptáculo, quando o poste guia é inserido dentro do receptáculo. Em um exemplo, o receptáculo compreende um elemento tubular alongado, dentro do qual o poste guia pode ser inserido, pelo menos uma abertura lateral (20) e um contato elétrico (21), que se estende a partir do exterior do elemento, para se projetar dentro da abertura, de modo a se conectar com o poste guia.
Patent EA-000112-B1 (EA)
Title: Compositions having antiviral properties and preparation process
Inventor: COMMIN ALIX-ROLAND
IPC: A61K36/33
Filed: 1996-02-13
Abstract: The compositions of the invention are prepared from acetic acid and coconut powder extracts, a solution of mineral salts, extracts of cactaceae, liliaceae, anacardiaceae and euphorbiaceae.
Patent EA-000061-B1 (EA)
Title: Substituted phenyl compounds as endothelin antagonists
Inventor: PORTER BARRY
IPC: C07D213/30
Filed: 1996-01-22
Abstract: Compounds of formula (I) are described, wherein: R<1> is CN, CH2CN, CH=CHCN, CHO, or CH=CHCO2H; R<2> is aryl lower alkoxy, heteroaryl lower alkoxy, aryl lower alkylthio or heteroaryl lower alkylthio in which each of the aryl and heteroaryl moieties is optionally substituted; R<3> is halogen; R<4> is optionally substituted aryl or optionally substituted heteroaryl; R<5> is carboxy or an acid isostere; X is oxygen or sulphur; and n is zero or 1; and their N-oxides and prodrugs, and pharmaceutically acceptable salts thereof. The compounds have endothelin antagonist activity and are useful as pharmaceuticals.
Patent EA-002784-B1 (EA)
Title: Complete switchgear
Inventor: MELNIK ROMAN IVANOVICH
IPC: H02B13/00
Filed: 2000-10-13
Abstract: A complete switchgear, comprising a cabinet, a current transformer compartment, a busbar compartment, a compartment of a carriage-type element with movable contacts, a ground, fixed upper and lower current-conducting contacts, characterized in that comprises a mechanism of travelling of the carriage-type element from working to a control position and back with doors closed, wherein a bushing insulator is arranged on a metal plate in a partition between the current transformer compartment and the compartment of the carriage-type element, an upper fixed current-conducting contact is fastened to the inner part of the bushing insulator, the contact is connected via a socket to the upper movable socket contact of the carriage-type element being in a working position, the lower current-conducting contact is rigidly fixed to the current transformers providing current passing through them and the current transformers in the working position of the carriage-type element, wherein partitions made of insulation material are arranged between the current transformer compartment and the compartment of the carriage-type element forming an air space providing an air insulation for the lower fixed current-conducting contact of the cabinet and the movable contact of the carriage-type element, and the facade doors, with a lifting-rotating lock device, fit tightly along the perimeter of the compartment of the carriage-type element.
Patent EA-004290-B1 (EA)
Title: SELECTIVE iGLuR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
Inventor: BLEAKMAN DAVID
IPC: A61P25/06
Filed: 2000-06-27
Abstract: 1. The use 3S,4aR,6S,8aR-6-(((4-carboxy) phenyl) methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid as a selective iGluR5 receptor antagonist for the manufacture of a medicament for treating migraine. 2. The use of a compound of formula I wherein R<1> and R<2> are each independently H, C1-C20 alkyl or a pharmaceutically acceptable salt thereof as the selective iGluR5 receptor antagonist for the manufacture of a medicament for treating migraine. 3. The use according to claim 2, characterized in that the compound of formula I is selected from 4aR,6S,8aR-6-(((2S)-2-(Ethoxycarbonyl)-4,4-difluoropyrrolidinyl)methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate, or 3S,4aR,6S,8Ar-6-(((2S)-2-(Carboxylic acid)-4,4difluoropyrrolidinyl) methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid. 4. A compound of formula wherein R<1> and R<2> are each independently H, C1-C20 alkyl or a pharmaceutically acceptable salt thereof. 5. The compound according to claim 4, characterized in that R<1> and R<2> are each independently H, C1-C6 alkyl. 6. A compound which is 3S,4aR,6S,8aR Ethyl 6-(((2S)-2-(Ethoxycarbonyl)-4,4 difluoropyrrolidinyl) methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate, or a pharmaceutically acceptable salt thereof. 7. A compound which is 3S,4aR,6S,8aR-6-(((2S)-2(Carboxylic acid)-4,4-difluoropyrrolidinyl) methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid, or a pharmaceutically acceptable salt thereof. 8. A pharmaceutical composition which comprises a compound according to any one of claims 4-7 in combination with one or more pharmaceutically acceptable carriers, diluents, or excipients. 9. A pharmaceutical composition for the treatment of migraine which comprises a compound according to any one of claims 4-7 in combination with a pharmaceutically acceptable carrier, diluent, or excipient. 10. A compound which is 3S,4aR,6S,8aR-Ethyl 6-(((2S)-2-(Ethoxycarbonyl)-4,4-difluoropyrrolidinyl) methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydrosioquionline-3-carboxylate mandelate.
Patent EA-008016-B1 (EA)
Title: Systems, apparatuses and methods for diamond color measurement and analysis
Inventor: DE JONG PETER
IPC: G01N21/87
Filed: 2001-02-06
Abstract: The present invention comprises systems, apparatuses and methods for measuring and analyzing gem color in a way which reliably and consistently simulates visual color analysis methodology. The preferred system embodiment of the present invention comprises several aspects, including the use of daylight approximating lamps (10), such as daylight approximating fluorescent tubes or halogen lamp boosted with a filter to approximate daylight, and a light detector which light of a specific angle such that the system approximates visual analysis methodology. In the case of diamond analysis, in one embodiment, the system of the invention includes three major elements: a daylight approximating light source (10) that illuminates the pavilion side of the diamond (40), a light detector (30) which detects light coming out at a specific angle from the pavilion side of the diamond (40), and an optical measurement device which measures the light detected by the light detector (30).
Patent EA-006168-B1 (EA)
Title: Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline
Inventor: DAVIS JOHN DOUGLAS
IPC: A61K47/38
Filed: 2002-09-30
Abstract: The invention provides a controlled-release pharmaceutical formulation for oral administration comprising 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable adjuvant, diluent or carrier; characterized in that the formulation is adapted to release at least 50% by weight of the 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)-quinazoline, or the pharmaceutically acceptable salt thereof, after 6 hours in Apparatus 1 described in the United States Pharmacopoeia 24 (2000), pp 1941-1943, having 1 litre vessels, baskets of 40 mesh (0.4 mm apertures), a rotation speed of 100 rpm, and a dissolution medium consisting of 900 ml of 0.01 M hydrochloric acid containing 0.7% w/v sodium chloride at 37 degree C. Formulations according to the invention are suitable for the treatment of BPH.
Patent EA-012926-B1 (EA)
Title: Pyrrolopyrimidine aselective antagonist compounds, their synthesis and use
Inventor: CASTELHANO ARLINDO L
IPC: A61P9/00
Filed: 2002-12-20
Abstract: The present invention relates to a compound having the structure wherein,Ris a substituted or unsubstituted (C-C) alkyl, wherein the substituent is hydroxyl, dihydroxy, carboxyl, -C(=O)NRR, -NRR, -NRC(=O)NRR, -NRC(=O)OR-OC(=O)NRR, or -NHC(=O)R; Ris hydrogen or a substituted or unsubstituted (C-C) alkyl, wherein the substituent is hydroxyl, carboxyl, -C(=O)NRR, -NRR, -NRC(=O)NRR, -NRC(=O)OR, -OC(=O)NRR, or -NHC(=O)R, where R, Rare each independently hydrogen or (C-C) alkyl; or R, Rand N together form a substituted piperazine, substituted azetidine ring, or a pyrrolidine ring substituted with -(CH)OH or –CHC(=O)OH; Ris phenyl; Ris hydrogen or substituted or unsubstituted (C-C) alkyl; Ris -(CH)OR, -CHNOR, -C(=O)NRR, -(CH)C(=O)OR, or -(CH)C(=O)NRR; wherein Ris a substituted or unsubstituted (C-C) alkyl, (C-C)cycloalkyl, heteroaryl or 4-8 membered heterocyclic ring or a substituted phenyl; where a substituent of the phenyl ring is selected from the group comprising –OCH, -CH, -C(=O) OCH, -NHor –NHC(=O) CH; Ris hydrogen, or a substituted or unsubstituted (C-C) alkyl, (C-C) alkylaryl ; Rand Rare each independently hydrogen, or a substituted or unsubstituted (C-C) alkyl, (C-C) alkylaryl, (C-C) alkylamino, (C-C) alkoxy, or a saturated or unsaturated, monocyclic or bicyclic, carbocyclic or heterocyclic ring, comprising N or S as a heteroatom, or R, N, and Rtogether form a substituted or unsubstituted 4-8 membered heterocyclic ring comprising N or O as a heteroatom; Ris hydrogen or a substituted or unsubstituted (C-C) alkyl, (C-C)cycloalkyl, or an aryl, heteroaryl or heterocyclic ring; R, N and Rtogether form a 4-8 membered heterocyclic ring comprising N or O as a heteroatom; m is 0, 1, 2 or 3 ; and k is 1, 2 or 3, or a specific enantiomer thereof, or a specific tautomer thereof, or a pharmaceutically acceptable salt thereof; to use of said compounds for preparing a medicament for the treatment of a disease associated with the Aadenosine receptor.
Patent EA-009433-B1 (EA)
Title: Gaming machine and gaming system
Inventor: OKADA KAZUO
IPC: A63F5/04
Filed: 2005-12-09
Abstract: There is provided a gaming machine or a gaming system which may provide a game player with an incentive to play a game repeatedly without lowering the player's anticipation for a shift to a special game mode. The gaming machine 1 A comprises shift determination means for determining whether a base game mode is shifted to a special game mode based on a first shift condition unless a game article 90 storing game related information is removed. If the game related information can be read from the game article 90 , shift determination to the special mode may be made under a second shift condition.
Patent EA-012124-B1 (EA)
Title: Method for stamping articles from sheet material and device therefor
Inventor: MELIKHOV ANATOLIJ VLADIMIROVICH
IPC: B21D22/06
Filed: 2007-08-07
Abstract: A method is proposed for stamping articles from sheet material and a device therefor. The invention relates to to cold sheet bending and can be used in all branches of machinery construction for drawing parts from sheet material. The device comprises a lower stationary and an upper movable matrices. A blank sheet is placed on the lower matrix shaped as a future part, then, using hydraulic cylinders the blank sheet is pressed by the upper matrix. Both matrices are connected by a hinge in the form of two loops fixed on both matrices and connected by an axis. The pivot-hinged connection permits to distribute loads from the hydraulic cylinders uniformly as well as evenly draw and bend blanks.
Patent EA-015668-B1 (EA)
Title: Multicrystalline p-type silicon wafers, having a high lifetime of minor carriage carrier and a method for production thereof
Inventor: ENEBAKK ERIK
IPC: H01L21/223
Filed: 2007-11-28
Abstract: The present invention relates to multicrystalline p-type silicon wafers with high lifetime. The silicon wafers contain 0.2-2.8 ppma boron and 0.06-2.8 ppma phosphorous and/or arsenic and have been subjected to phosphorous diffusion and phosphorous gettering at a temperature of above 925 °C. The invention further relates to a method for production of such multicrystalline silicon wafers and to solar cells comprising such silicon wafers.
Patent EA-020145-B1 (EA)
Title: Hydrolases, nucleic acids encoding them and methods for making and using them
Inventor: BARTON NELSON R
IPC: A23L33/00
Filed: 2009-08-28
Abstract: Provided are hydrolases, including lipases, saturases, palmitases and/or stearatases, and polynucleotides encoding them, and methods of making and using these polynucleotides and polypeptides. Further provided are polypeptides, e.g., enzymes, having a hydrolase activity, e.g., lipases, saturases, palmitases and/or stearatases and methods for preparing low saturate or low trans fat oils, such as low saturate or low trans fat animal or vegetable oils, e.g., soy or canola oils.
Patent EA-028337-B1 (EA)
Title: Finite element modelling of borehole seismic responses in layered anisotropic formations and its use for elastic inversion
Inventor: JOERGENSEN OLE
IPC: G01V1/50
Filed: 2010-02-10
Abstract: A method of simulating a borehole acoustic response in an anisotropic formation of the crust of the earth, the method comprising formulating a geometric model of the formation, the geometric model comprising a plurality of layers definable in a cylindrical coordinate system defined by an axial direction normal to each of the layers, a radial direction relative to the axial direction, and a circumferential direction relative to the axial direction; formulating a computational model of wave propagation in the formation, the computational model comprising one or more field variables and a wave equation describing a behaviour of the one or more field variables, wherein the one or more field variables are represented as respective Fourier series expansions of p-periodic harmonics in the circumferential direction, and numerically solving the computational model.
Patent EA-021048-B1 (EA)
Title: 6-amino-2-{[(1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8h-purin-8-one maleate
Inventor: GIBBON ROBERT HERMANN
IPC: C07D473/18
Filed: 2011-02-08
Abstract: A compound which is 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-onein the form of a maleate salt, may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.
Patent EA-029716-B1 (EA)
Title: Use of als inhibitor herbicides for control of unwanted vegetation in als inhibitor herbicide tolerant brassica, such as b. napus, plants
Inventor: HAIN RUEDIGER
IPC: A01P13/00
Filed: 2012-05-04
Abstract: The present invention relates to the use of the ALS inhibitor herbicides for controlling unwanted vegetation in ALS inhibitor herbicide tolerant Brassica plants, more especially, the present invention relates to the use of ALS inhibitor herbicides for control of unwanted vegetation in Brassica growing areas which Brassica plants comprise non-transgenic mutations of their endogenous acetolactate synthase (ALS) genes I and III.
Patent EA-030163-B1 (EA)
Title: Oil extraction assembly, process for assembling such an assembly and process for manufacturing an oil extraction pipe thread protector
Inventor: DROUIN ALEXIS
IPC: F16L57/00
Filed: 2011-09-01
Abstract: The invention relates to an assembly comprising an oil extraction pipe (4) having a thread and a protector (1) for the thread of the extraction pipe (4), said protector (1) including a body and a thread complementary to that of the extraction pipe (4). the assembly being characterised in that it also comprises an elastomer film (60) affixed to the protector and designed to form a sealed connection between the extraction pipe (4) and the protector (1) when the protector (1) is positioned on the extraction pipe (4).